DNA Virus (SV40) Induced Antigens

  • Satvir S. Tevethia
  • Mary J. Tevethia
Part of the Cancer book series (C, volume 4)


DNA-containing tumor viruses, in contrast to RNA tumor viruses, differ from one another in morphology, nucleic acid content, host range, mode of replication, and ability to cause neoplasia in their natural host (Green, 1970). They include viruses which cause neoplasia in the host in which they replicate (herpesviruses) and viruses that induce tumors in the experimental animals in which they undergo abortive infection (papovaviruses, adenoviruses). Great variations exist within each group of DNA tumor viruses: some members of the papovavirus group induce tumors in their natural host (papilloma viruses) and others induce tumors in a heterologous host only (SV40, human papovaviruses).


Cellular Immune Response Simian Virus Permissive Temperature Peritoneal Exudate Cell Embryonic Antigen 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Allison, A. C., and Law, L. W., 1968, Effects of antilymphocyte serum on virus oncogenesis, Proc. Soc. Exp. Biol. Med. 127:207.PubMedGoogle Scholar
  2. Allison, A. C., Chesterman, F. C., and Baron, S., 1967, Induction of tumors in adult hamsters with simian virus 40, J. Natl. Cancer Inst. 38:567.PubMedGoogle Scholar
  3. Alstein, A. D., 1967, Oncogenic and transforming activity of hydroxylamine-inactivated SV40 virus, Virology 33:746.CrossRefGoogle Scholar
  4. Ambrose, K. R., Anderson, N. G., and Coggin, J. H., 1971a, Interruption of SV40 oncogenesis with human foetal cells, Nature (London) 233:194.CrossRefGoogle Scholar
  5. Ambrose, K. R., Anderson, N. G., and Coggin, J. H., 1971b, Cytostatic antibody and SV40 tumor immunity in hamsters, Nature (London) 233:321.CrossRefGoogle Scholar
  6. Ashkenazi, A., and Melnick, J. L., 1962, Induced latent infection of monkeys with vaculating SV40 papovavirus in kidneys and urine, Proc. Soc. Exp. Biol. Med. 111:367.PubMedGoogle Scholar
  7. Baldwin, R. W., Embleton, M. J., Price, M.R., and Vose, B.M., 1974, Embryonic antigen expression on experimental rat tumors, Transplant. Rev. 20:77.PubMedGoogle Scholar
  8. Black, P. H., Rowe, W. P., Turner, H. C., and Huebner, R. J., 1963, A specific complement-fixing antigen present in SV40 tumor and transformed cells, Proc. Natl. Acad. Sci. U.S.A. 50:1148.PubMedCrossRefGoogle Scholar
  9. Blasecki, J. W., and Tevethia, S. S., 1973, In vitro: assay of cellular immunity to tumor specific antigen(s) of virus-induced tumors by macrophage migration inhibition, J. Immunol. 110:590.PubMedGoogle Scholar
  10. Blasecki, J. W., and Tevethia, S. S., 1975, Cell mediated immunity to tumors induced by SV40 transformed cells. I. In vitro studies on the immune response of lymphoid cells from tumor bearing mice, J. Immunol. 114:244.PubMedGoogle Scholar
  11. Butel, J. S., Guentzel, M. J., and Rapp, F., 1969, Variants of defective simian papovavirus 40 (PARA) characterized by cytoplasmic localization of simian papovavirus 40 tumor antigen, J. Virol. 4:632.PubMedGoogle Scholar
  12. Butel, J. S., Tevethia, S. S., and Nachtigal, M., 1971, Malignant transformation in vitro by “nononcogenic” variants of defective SV40 (PARA). J. Immunol. 106:969.PubMedGoogle Scholar
  13. Butel, J. S., Tevethia, S. S., and Melnick, J. L., 1972, Oncogenicity and cell transformation by papovavirus SV40: The role of viral genome, Adv. Cancer Res. 15:1.PubMedCrossRefGoogle Scholar
  14. Butel, J. S., Brugge, J. S., and Noonan, C. A., 1974, Transformation of primate and rodent cells by temperature sensitive mutants of SV40, Cold Spring Harbor Symp. Quant. Biol. 39: in press.Google Scholar
  15. Carroll, R. B., Hager, L., and Dulbecco, R., 1974, Simian virus 40 T antigen binds to DNA, Proc. Natl. Acad. Sc:. U.S.A. 71:3754.CrossRefGoogle Scholar
  16. Chou, J. Y., and Martin, R. B., 1974, Complementation analysis of simian virus 40 mutants, J. Virol 13:1101.PubMedGoogle Scholar
  17. Coggin, J. H., and Ambrose, K. R., 1969, A rapid in vivo assay for SV40 tumor immunity in hamsters, Proc. Soc. Exp. Biol. 130:246.PubMedGoogle Scholar
  18. Coggin, J. H., and Anderson, N. G., 1974, Cancer, differentiation and embryonic antigens: Some central problems, Adv. Cancer Res. 19:105.PubMedCrossRefGoogle Scholar
  19. Coggin, J. H., Larson, V. M., and Hilleman, M. R., 1967, Immunologic responses in hamsters to homologous tumor antigens measured in vivo and in vitro, Proc. Soc. Exp. Biol. Med. 124:1295.PubMedGoogle Scholar
  20. Coggin, J. H., Ambrose, K. R., Bellamy, B. B., and Anderson, N. G., 1971, Tumor immunity in hamsters immunized with fetal tissue, J. Immunol. 107:520.Google Scholar
  21. Collins, J. J., Black, P. H., Strosberg, A. D., Haber, E., and Bloch, K. J., 1974, Transformation by simian virus 40 of spleen cells from a hyperimmune-rabbit: Evidence for synthesis of immunoglobulin by the transformed cells, Proc. Natl. Acad. Sci. U.S.A. 71:260.PubMedCrossRefGoogle Scholar
  22. Defendi, V., and Jensen, F., 1967, Oncogenicity by DNA tumor viruses: Enhancement after ultraviolet and cobalt-60 radiations, Science 157:703.PubMedCrossRefGoogle Scholar
  23. Deichman, G. I., 1969, Immunological aspects of carcinogenesis by deoxyrubonucleic acid tumor viruses, Adv. Cancer Res. 12:101.PubMedCrossRefGoogle Scholar
  24. Deichman, G. I., and Kluchareva, T. E., 1966, Loss of transplantation antigen in primary simian virus 40 tumors and their metastasis, J. Natl. Cancer Inst. 36:647.PubMedGoogle Scholar
  25. Deinhardt, F. W., Falk, L. A., and Wolf, L. G., 1974, Simian herpes viruses and neoplasia, Adv. Cancer Res. 19:167.PubMedCrossRefGoogle Scholar
  26. Del Villano, B. C., and Defendi, V., 1973, Characterization of SV40 T antigen, Virology 51:34.PubMedCrossRefGoogle Scholar
  27. Diamandopoulos, G. T., 1973, Induction of lymphocytic leukemia, lymphosarcoma, reticulum cell sarcoma and osteogenic sarcoma in the Syrian golden hamster by oncogenic DNA simian virus 40, J. Natl. Cancer Inst. 50:1347.PubMedGoogle Scholar
  28. Diamandopoulos, G. T., and Mclane, M. F., 1974, Development of antibodies to viral and tumor antigens before tumor induction, J. Immunol. 13:1450.Google Scholar
  29. Diamandopoulos, G. T., Tevethia, S. S., Rapp, F., and, Enders, J. F., 1968, Development of S and T antigens and oncogenicity in hamster embryonic cell lines exposed to SV40, Virology 34:331.PubMedCrossRefGoogle Scholar
  30. Dougherty, R. M., and Distefano, H. S., 1974, Isolation and characterization of a papovavirus from human urine, Proc. Soc. Exp. Biol. Med. 146:481.PubMedGoogle Scholar
  31. Drapkin, M. S., Appella, E., and Law, L. W., 1974, Immunogenic properties of a soluble tumor specific transplantation antigen induced by simian virus 40, J. Natl. Cancer Inst. 52:259.PubMedGoogle Scholar
  32. Dubbs, D. R., Rachmeler, M., and Kit, S., 1974, Recombination between temperature-sensitive mutants of simian virus 40, Virology 57:161.PubMedCrossRefGoogle Scholar
  33. Duff, R., and Rapp, F., 1970, Quantitative characteristics of the transformation of hamster cells by PARA (defective simian virus 40)-adenovirus 7, J. Virol. 5:568.PubMedGoogle Scholar
  34. Eddy, B., 1964, Simian virus 40 (SV40); an oncogenic virus, Proc. Exp. Tumor Res. 4:1.Google Scholar
  35. Estes, M. K., Huang, E. S., and Pagano, J. S., 1971, Structural polypeptides of simian virus 40, J. Virol. 7:635.PubMedGoogle Scholar
  36. Gardner, S. D., Field, A. M., Coleman, D. V., and Hulme, B., 1971, New human papovavirus (B.K.) isolated from urine after renal transplantation, Lancet 1:1253.PubMedCrossRefGoogle Scholar
  37. Girardi, A. J., 1965, Prevention of SV40 virus oncogenesis in hamsters. I. Tumor resistance induced by human cells transformed by SV40, Proc. Natl. Acad. Sci. U.S.A. 54:445.PubMedCrossRefGoogle Scholar
  38. Girardi, A. J., 1967, Tumor resistance and tumor enahancement with SV40 virus-induced tumors, in: Germinal Centers in Immune Responses (H. Cottier, N. Odartchenko, R. Schindler, and C. C. Congdon, eds.), ph. 422–427, Springer, New York.CrossRefGoogle Scholar
  39. Girardi, A. J., and Defendi, V., 1970, Induction of SV40 transplantation antigen (Tr Ag) during the lytic cycle, Virology 42:688.PubMedCrossRefGoogle Scholar
  40. Girardi, A. J., and Roosa, R. A., 1967, Prevention of SV40 virus oncogenesis in hamsters. II. The effect of thymectomy on induction of tumor resistance by SV40 transformed human cells, J. Immunol. 99:1217.PubMedGoogle Scholar
  41. Girardi, A. J., Reppucci, P., Dierlam, P., Rutala, W., and Coggin, J. H., 1973, Prevention of simian virus 40 tumors by hamster fetal tissue: Influence of parity status of donor females on immunogenic-ity of fetal tissue and on immune cell cytotoxicity, Proc. Natl. Acad. Sci. U.S.A. 70:183.PubMedCrossRefGoogle Scholar
  42. Green, M., 1970, Oncogenic viruses, Ann. Rev. Biochem. 39:701.PubMedCrossRefGoogle Scholar
  43. Hayry, P., and Defendi, V., 1968, Use of mixed hemagglutination technique in detection of virus-induced antigen(s) on SV40 transformed cell surface, Virology 36:317.PubMedCrossRefGoogle Scholar
  44. Hayry, P., and Defendi, V., 1970, Surface antigen(s) of SV40 transformed tumor cells, Virology 41:22.PubMedCrossRefGoogle Scholar
  45. Khera, K. S., Ashkenazi, A., Rapp, F., and Melnick, J. L., 1963, Immunity in hamsters to cells transformed in vitro and in vivo by SV40: Tests for antigenic relationship among papovavirus, J. Immunol. 91:604.PubMedGoogle Scholar
  46. Kit, S., Kurimura, T., and Dubbs, D. R., 1969, Transplantable mouse tumor line induced by injection of SV40 transformed mouse kidney cells, Int. J. Cancer 4:384.PubMedCrossRefGoogle Scholar
  47. Klein, G., 1971, Immunological aspects of Burkitts, lymphoma, Adv. Immunol. 14:187.PubMedCrossRefGoogle Scholar
  48. Kluchareva, T. E., Shachanina, K. L., Belova, S., Chibisova, V., and Deichman, G. I., 1967, Use of immunofluorescence for detection of specific membrane antigens in simian virus 40-infected nontransformed cells, J. Natl. Cancer Inst. 39:825.PubMedGoogle Scholar
  49. Lai, C., and Nathans, D., 1974, Mapping temperature-sensitive mutants of simian virus 40: Rescue of mutants by fragments of viral DNA, Virology 60:461.CrossRefGoogle Scholar
  50. Lausch, R. N., Tevethia, S. S., and Rapp, F., 1970, Evidence for tolerance to SV40 tumor antigen in hamsters bearing PARA-adenovirus 12 tumor transplants, J. Immunol. 104:305.PubMedGoogle Scholar
  51. Levin, M. J., Oxman, M. N., Diamandopoulos, G. T., Levine, A. S., Henry, P. H., and Enders, J. F., 1969, Virus-specific nucleic acids in SV40 exposed hamster embryo cell lines: Correlation with S and T antigens, Proc. Natl. Acad. Sci. U.S.A. 62:589.PubMedCrossRefGoogle Scholar
  52. Levine, A. S., Oxman, M. N., Henry, P. H., Levin, J. J., Diamandopoulos, G. T., and Enders, J. F., 1970, Virus-specific deoxyribonucleic acid in simian virus 40 exposed hamster cells: Correlation with S and T antigens, J. Virol. 6:199.PubMedGoogle Scholar
  53. Lewis, A. M., and Rowe, W. P., 1971, Studies on nondefective adenovirus simian virus 40 hybrid viruses. I. A newly characterized simian virus 40 antigen induced by the Ad2+ND, virus, J. Virol. 7:189.PubMedGoogle Scholar
  54. Lewis, A. M., and Rowe, W. P., 1973, Studies of nondefective adenovirus 2-simian virus 40 hybrid viruses. VIII. Association of simian virus 40 transplantation antigen with a specific region of the early viral genome, J. Virol. 12:836.PubMedGoogle Scholar
  55. Metzgar, R. S., and Oleinick, S. R., 1968, The study of normal and malignant cell antigens by mixed agglutination, Cancer Res. 28:1366.PubMedGoogle Scholar
  56. Osborne, M., and Weber, K., 1973, Abstract, Cold Spring Harbor Tumor Virus Meeting.Google Scholar
  57. Oxman, M. N., and Black, P. H., 1966, Inhibition of SV40 T antigen formation by interferon, Proc. Natl. Acad. Sci. U.S.A. 55:1133.PubMedCrossRefGoogle Scholar
  58. Padgett, B. L., Walker, D. L., Zurhein, G. M., Eckroade, R. J., and Delsel, B. H., 1971, Cultivation of papova-like virus from human brain with progressive multifocal leukoencephalopathy, Lancet 1:1257.PubMedCrossRefGoogle Scholar
  59. Pope, J. H., and Rowe, W. P., 1964, Detection of specific antigen in SV40 transformed cells by immunofluorescence, J. Exp. Med. 120:121.PubMedCrossRefGoogle Scholar
  60. Prehn, R., 1972, The immune reaction as a stimulator of tumor growth, Science 176:170.PubMedCrossRefGoogle Scholar
  61. Rabson, A. S., O’Conner, G. T., Kirschstein, R. L., and Branigan, V. J., 1962, Papillary ependymomas produced in Rattus (Mastomys) natalensis inoculated with vacuolating virus (SV40), J. Natl. Cancer Inst. 29:765.PubMedGoogle Scholar
  62. Rapp, F., 1973, The PARA-adenoviruses, Proc. Exp. Tumor Res. 18:104.Google Scholar
  63. Raph, F., 1974, Herpes viruses and cancer, Adv. Cancer Res. 19:268.Google Scholar
  64. Rapp, F., Butel, J. S., and Melnick, J. L., 1964a, Virus induced intranuclear antigen in cells transformed by papovavirus SV40, Proc. Soc. Exp. Biol. 116:1131.PubMedGoogle Scholar
  65. Rapp, F., Kitahara, T., Butel, J. S., and Melnick, J. L., 1964b, Synthesis of SV40 tumor antigen during replication of simian papovavirus (SV40) Proc. Natl. Acad. Sci. U.S.A. 52:1138.PubMedCrossRefGoogle Scholar
  66. Raph, F., Butel, J. S., Feldman, L. A., Kitahara, T., and Melnick, J. L., 1965, Differential effects of inhibitors on the steps leading to the formation of SV40 tumor and virus antigens, J. Exp. Med. 121:935.CrossRefGoogle Scholar
  67. Rapp, F., Tevethia, S. S., Rawls, W. E., and Melnick, J. L., 1967, Production of antibodies to papovavirus SV40 tumor antigen in African green monkeys, Proc. Soc. Exp. Biol. Med. 125:794.PubMedGoogle Scholar
  68. Riggs, J. L., Takemori, N., and Lennette, E. H., 1968, Cross reactivity between T antigens of adenoviral immunotypes of proved and currently unproved oncogenic potential, J. Immunol. 100:348.PubMedGoogle Scholar
  69. Robb, J. A., Tegtmeyer, P. Ishikawa, A., Stark, G. R., and Ozer, H. L., 1974, Antigenic phenotypes and complementation groups of temperature-sensitive mutants of simian virus 40, Virology 13:677.Google Scholar
  70. Sambrook, J., 1973, Transformation by polyoma virus and simian virus 40, Adv. Cancer Res. 16:141.CrossRefGoogle Scholar
  71. Takemoto, K. K., and Mullarkey, M. F., 1973, Human papovaviruses, BK strain: Biological studies including antigenic relationship to simian virus 40, J. Virol. 12:625.PubMedGoogle Scholar
  72. Takemoto, K. K., Ting, R. C. Y., Ozer, H. L., and Fabisch, P., 1968, Establishment of a cell line from an inbred mouse strain for viral transformation studies: Simian virus 40 transformation and tumor production, J. Natl. Cancer Inst. 41:1401.PubMedGoogle Scholar
  73. Tegtmeyer, P., 1972, Simian virus 40 deoxyribonucleic acid synthesis: The viral replicon, J. Virol. 10:591.PubMedGoogle Scholar
  74. Tegtmeyer, P., and Ozer, H. L., 1971, Temperature-sensitive mutants of simian virus 40: Infection of permissive cells, J. Virol. 8:516.PubMedGoogle Scholar
  75. Tevethia, S. S., 1967, Characterization of hamster antibody reacting with papovavirus SV40 tumor antigen, J. Immunol. 98:1257.PubMedGoogle Scholar
  76. Tevethia, S. S., 1970, Immune response of rabbits to purified papovavirus SV40, J. Immunol. 104:72.PubMedGoogle Scholar
  77. Tevethia, S. S., 1974, Evidence for virus-specific transplantation antigen in cells of lymphoid neoplasms induced by papovavirus SV40, Int. J. Cancer 13:494.PubMedCrossRefGoogle Scholar
  78. Tevethia, S. S., and Mcmillan, V. L., 1973, In vitro induction of tumor specific transplantation antigen in mouse cells abortively infected with papovavirus SV40, Proc. Am. Assoc. Cancer Res. 13:57.Google Scholar
  79. Tevethia, S. S., and Mcmillan, V. L., 1974, Acquisition of malignant potential by SV40 transformed cells: Relationship to type C viral antigen expression, Intervirology (in press).Google Scholar
  80. Tevethia, S. S., Katz, M., and Rapp, F., 1965, New surface antigen in cells transformed by simian papovavirus SV40, Proc. Soc. Exp. Biol. (N.Y.) 119:896.Google Scholar
  81. Tevethia, S. S., Couvillon, L. A., and Rapp, F., 1968a, Development in hamsters of antibodies against surface antigens present in cells transformed by papovavirus SV40, J. Immunol. 100:358.PubMedGoogle Scholar
  82. Tevethia, S. S., Diamandopoulos, G. T., Rapp, F., and Enders, J. F., 1968b, Lack of relationship between virus-specific and transplantation antigens in hamster cells transformed by simian papovavirus SV40, J. Immunol. 101:1192.PubMedGoogle Scholar
  83. Tevethia, S. S., Dreesman, G. R., Lausch, R. N., and Rapp, F., 1968c, Effect of anti-hamster thymocyte serum on papovavirus DV40 induced transplantation immunity, J. Immunol. 101:1105.Google Scholar
  84. Tevethia, S. S., Crouch, N. A., Melnick, J. L., and Rapp, F., 1970, Detection of specific surface antigens by colony inhibition in cells transformed by papovavirus SV40, Int. J. Cancer 5:176.PubMedCrossRefGoogle Scholar
  85. Tevethia, S. S., Mcmillan, V. L., Kaplan, P. M., and Bushong, S. C., 1971, Variation in immunosensitivity of SV40 transformed hamster cells, J. Immunol. 106:1295.PubMedGoogle Scholar
  86. Tevethia, S. S., Blasecki, J. W., Waneck, G., and Goldstein, A., 1974, Requirement of thymus derived θ positive lymphocytes for rejection of DNA virus (SV40) tumors in mice, J. Immunol. 113:1417.PubMedGoogle Scholar
  87. Ting, C. C., and Herberman, R. B., 1971, Detection of tumor-specific antigen of simian virus 40 induced tumors by the isotopic antiglobulin technique, Int. J. Cancer 7:499.PubMedCrossRefGoogle Scholar
  88. Ting, C. C., Larvin, D. H., Shiv, G., and Herberman, R. B., 1972, Expression of fetal antigens in tumor cells, Proc. Natl. Acad. Sci. U.S.A. 69:1664.PubMedCrossRefGoogle Scholar
  89. Ting, C. C., Rodrigues, D., and Herberman, R. B., 1973, Expression of fetal antigens and tumor specific antigens in SV40 transformed cells. II. Tumor transplantation studies, Int. J. Cancer 12:519.PubMedCrossRefGoogle Scholar
  90. Todaro, G. J., and Huebner, R. J., 1972, The viral oncogene hypothesis: New evidence, Proc. Natl. Acad. Sci. U.S.A. 69:1009.PubMedCrossRefGoogle Scholar
  91. Uchida, S., and Watanabe, S., 1968, Tumorigenicity of the antigen-forming defective virions of simian virus 40, Virology 35:166.PubMedCrossRefGoogle Scholar
  92. Walker, D. L., Padgett, B. L., Zu Rhein, G. M., Albert, A. E., and Marsh, R. F., 1973, Human papovavirus (JC): Induction of brain tumors in hamsters, Science 181:674.PubMedCrossRefGoogle Scholar
  93. Weiner, L. P., Herndon, R. M., Narayan, O., and Johnson, R. T., 1972, Further studies of a simian virus 40 like virus isolated from human brain, J. Virol. 10:147.PubMedGoogle Scholar
  94. Wright, P. W., and Law, L. W., 1971, Quantitative in vitro measurement of simian virus 40 tumor-specific antigens, Proc. Natl. Acad. Sci. U.S.A. 68:973.PubMedCrossRefGoogle Scholar
  95. Zarling, J. M., and Tevethia, S. S., 1973a, Transplantation immunity to simian virus 40 transformed cells in tumor bearing mice. I. Development of cellular immunity to simian virus 40 tumor specific transplantation antigens during tumorigenesis by transformed cells, J. Natl. Cancer Inst. 50:137.PubMedGoogle Scholar
  96. Zarling, J. M., and Tevethia, S. S., 1973b, Transplantation immunity to simian virus 40 transformed cells in tumor bearing mice. II. Evidence for macrophage participation of the effector level of tumor cell rejection, J. Natl. Cancer Inst. 50:149.PubMedGoogle Scholar

Copyright information

© Plenum Press, New York 1975

Authors and Affiliations

  • Satvir S. Tevethia
    • 1
  • Mary J. Tevethia
    • 1
  1. 1.Department of Pathology and Cancer Research CenterTufts University School of MedicineBostonUSA

Personalised recommendations